Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Modellportföljen: Revenios vikt stiger i portföljen i och med nyemissionen

REG1VResearch2026-09-28 09:11
Juha Kinnunen, Atte Riikola, Rauli Juva
Discuss

Automatisk översättning: Ursprungligen publicerad på finska 2026-09-28 07:11 GMT. Ge feedback här.

Modellportföljen utnyttjar alla sina teckningsrätter i Revenio och köpte dessutom 471 rätter, med vilka vi tecknar totalt 756 nya aktier i bolagets emission av teckningsrätter till en styckpris på 6,19 euro. Vår totala investering uppgår till ungefär 5 600 euro. Vi utförde åtgärderna måndagen den 28 september när teckningsperioden och handeln med teckningsrätter inleddes. Efter emissionen är Revenios vikt i Modellportföljen ungefär 8 % och likviditetsvikten ungefär 7 %.

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more on company page

Key Estimate Figures23/09

202526e27e
Revenue109.7200.2269.6
growth-%6.0 %82.5 %34.7 %
EBIT (adj.)26.532.244.8
EBIT-% (adj.)24.2 %16.1 %16.6 %
EPS (adj.)0.580.670.67
Dividend0.000.000.00
Dividend %
P/E (adj.)33.015.915.7
EV/EBITDA16.719.111.0

Forum discussions

To answer in the same way; as I understand it, 1,065 shares, meaning 1,065 subscription rights divided by 9 makes 118 full bundles of 9 plus...
4 hours ago
by Optis
5
KL: Kauppalehti: The health tech company Revenio, known for its intraocular pressure meters, began a rights offering on Monday, offering nearly...
4 hours ago
by Alamäki
2
Did I get this right: I own 1065 Revenio shares. I want to use all subscription rights. 1065 (divided by nine) (times four) = 473.3. The amount...
5 hours ago
by Sami Valonen
0
To bring a little variety to the Revendedores (Reven) brand hype, a recent scientific article reveals that the vast majority of ophthalmologists...
6 hours ago
by veronmaksaja
4
You would think they can be found under corporate actions. I’m not a Danske customer, but they accept subscriptions/allocations there. So you...
7 hours ago
by äspee
0
Apparently, I just have to sell if it’s possible, since there’s no opportunity to buy… This is something else…
7 hours ago
by Abraham
0
I have my shares in Danske Bank’s equity savings account (osakesäästötili), and subscribing to new shares didn’t work. I got a warning like ...
7 hours ago
by Abraham
0